文献速递精神分裂症与精神病性障碍

嵌合染色体改变对精神分裂症的贡献

The Contribution of Mosaic Chromosomal Alterations to Schizophrenia.
PubMed 文献 · Biol Psychiatry · 2024-06-26

该研究分析9715例精神分裂症患者和28822名中国裔对照者的血液基因型阵列,用MoChA工具检测嵌合染色体改变,发现患者体细胞丢失检出率显著高于对照(1.00% vs. 0.52%),并在中国队列和PGC数据中识别出多个与精神分裂症相关的复发性体细胞拷贝数变异区域。

要点

  • 精神分裂症患者体细胞丢失检出率显著高于对照(1.00% vs. 0.52%;OR=1.91;95%CI 1.47-2.49;P=1.49×10⁻⁶)。
  • 随着细胞分数cutoff增加,OR从1.91升至2.78。
  • 中国队列识别出10q21.1(ZWINT)、3q26.1(SLITRK3)、1q31.1(BRINP3)和12q21.31-21.32(MGAT4C和NTS)等复发性sCNVs区域。

核心结论

  • 研究强调嵌合染色体改变对精神分裂症有显著影响,提示其在该障碍遗传病因学中可能起关键作用。

研究设计与样本

  • 分析9715例精神分裂症患者和28822名中国裔对照者的血液基因型阵列,用基于长程染色体信息的计算工具MoChA检测嵌合染色体改变。
  • 通过严格过滤聚焦可能源于早期发育的体细胞拷贝数变异(sCNVs)。
  • 整合PGC数据集(12834例精神分裂症病例和11648名欧洲裔对照)以及936名参与者(449例病例和487名对照)的死后脑组织基因分型数据。

主要发现

  • 精神分裂症患者体细胞丢失检出率显著高于对照(1.00% vs. 0.52%;OR=1.91;95%CI 1.47-2.49;双侧Fisher精确检验P=1.49×10⁻⁶)。
  • 随着细胞分数cutoff增加,OR成比例升高(从1.91升至2.78)。
  • 中国队列识别出与精神分裂症相关的复发性sCNVs(OR>8;Fisher精确检验P<.05),包括10q21.1(ZWINT)、3q26.1(SLITRK3)、1q31.1(BRINP3)和12q21.31-21.32(MGAT4C和NTS)等区域,部分区域在PGC数据中得到验证。
  • 跨组织验证定位到1p35.3-35.2和19p13.3-13.2等位点的体细胞丢失。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mosaic chromosomal alterations are implicated in neuropsychiatric disorders, but the contribution to schizophrenia (SCZ) risk for somatic copy number variations (sCNVs) emerging in early developmental stages has not been fully established. METHODS: We analyzed blood-derived genotype arrays from 9715 patients with SCZ and 28,822 control participants of Chinese descent using a computational tool (MoChA) based on long-range chromosomal information to detect mosaic chromosomal alterations. We focused on probable early developmental sCNVs through stringent filtering. We assessed the burden of sCNVs across varying cell fraction cutoffs, as well as the frequency with which genes were involved in sCNVs. We integrated this data with the PGC (Psychiatric Genomics Consortium) dataset, which comprises 12,834 SCZ cases and 11,648 controls of European descent, and complemented it with genotyping data from postmortem brain tissue of 936 participants (449 cases and 487 controls). RESULTS: Patients with SCZ had a significantly higher somatic losses detection rate than control participants (1.00% vs. 0.52%; odds ratio = 1.91; 95% CI, 1.47-2.49; two-sided Fisher's exact test, p = 1.49 × 10-6). Further analysis indicated that the odds ratios escalated proportionately (from 1.91 to 2.78) with the increment in cell fraction cutoffs. Recurrent sCNVs associated with SCZ (odds ratio > 8; Fisher's exact test, p < .05) were identified, including notable regions at 10q21.1 (ZWINT), 3q26.1 (SLITRK3), 1q31.1 (BRINP3) and 12q21.31-21.32 (MGAT4C and NTS) in the Chinese cohort, and some regions were validated with PGC data. Cross-tissue validation pinpointed somatic losses at loci like 1p35.3-35.2 and 19p13.3-13.2. CONCLUSIONS: The study highlights the significant impact of mosaic chromosomal alterations on SCZ, suggesting their pivotal role in the disorder's genetic etiology.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Chang K, Jian X, Wu C, et al. The Contribution of Mosaic Chromosomal Alterations to Schizophrenia. Biol Psychiatry. 2024. PMID: 38942348. doi:10.1016/j.biopsych.2024.06.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。